Abstract
Objective
We aimed to clarify the impact of extracorporeal membrane oxygenation (ECMO) as a platform to drive hemodialysis (HD) for ammonia clearance on outcomes of neonates with severe hyperammonemia.
Study design
All neonates treated for hyperammonemia at a single children’s hospital between 1992 and 2016 were identified. Patient characteristics and outcomes were compared between those receiving medical management or ECMO/HD.
Result
Twenty-five neonates were treated for hyperammonemia, of which 13 (52%) received ECMO/HD. Peak ammonia levels among neonates treated with ECMO/HD were significantly higher than those medically managed (1041 [IQR 902–1581] μmol/L versus 212 [IQR 110–410] μmol/L; p = 0.009). Serum ammonia levels in the ECMO/HD cohort declined to the median of medically managed within 4.5 (IQR 2.9–7.0) hours and normalized within 7.3 (IQR 3.6–13.5) hours. All neonates survived ECMO/HD, and nine (69.2%) survived to discharge.
Conclusion
ECMO/HD is an effective adjunct to rapidly clear severe hyperammonemia in newborns, reducing potential neurodevelopmental morbidity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Picca S, Dionisi-Vici C, Bartuli A, De Palo T, Papadia F, Montini G, et al. Short-term survival of hyperammonemic neonates treated with dialysis. Pediatr Nephrol. 2015;30:839–47.
Summar M. Current strategies for the management of neonatal urea cycle disorders. J Pediatr. 2001;138 Suppl 1:S30–9.
Tuchman M, Lee B, Lichter-Konecki U, Summar ML, Yudkoff M, Cederbaum SD, et al. Cross-sectional multicenter study of patients with urea cycle disorders in the United States. Mol Genet Metab. 2008;94:397–402.
Campbell AG, Rosenberg LE, Snodgrass PJ, Nuzum CT. Ornithine transcarbamylase deficiency: a cause of lethal neonatal hyperammonemia in males. N Engl J Med. 1973;288:1–6.
Kolker S, Garcia-Cazorla A, Valayannopoulos V, Lund AM, Burlina AB, Sykut-Cegielska J, et al. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab Dis. 2015;38:1041–57.
Summar M, Pietsch J, Deshpande J, Schulman G. Effective hemodialysis and hemofiltration driven by an extracorporeal membrane oxygenation pump in infants with hyperammonemia. J Pediatr. 1996;128:379–82.
Batshaw ML. Inborn errors of urea synthesis. Ann Neurol. 1994;35:133–41.
Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits ED. Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. N Engl J Med. 1984;310:1500–5.
Deodato F, Boenzi S, Rizzo C, Abeni D, Caviglia S, Picca S, et al. Inborn errors of metabolism: an update on epidemiology and on neonatal-onset hyperammonemia. Acta Paediatr Suppl. 2004;93:18–21.
Wong KY, Wong SN, Lam SY, Tam S, Tsoi NS. Ammonia clearance by peritoneal dialysis and continuous arteriovenous hemodiafiltration. Pediatr Nephrol. 1998;12:589–91.
Arbeiter AK, Kranz B, Wingen AM, Bonzel KE, Dohna-Schwake C, Hanssler L, et al. Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism. Nephrol Dial Transplant. 2010;25:1257–65.
Donn SM, Swartz RD, Thoene JG. Comparison of exchange transfusion, peritoneal dialysis, and hemodialysis for the treatment of hyperammonemia in an anuric newborn infant. J Pediatr. 1979;95:67–70.
Snyderman SE, Sansaricq C, Phansalkar SV, Schacht RC, Norton PM. The therapy of hyperammonemia due to ornithine transcarbamylase defiency in a male neonate. Pediatrics. 1975;56:65–73.
Wiegand C, Thompson T, Bock GH, Mathis RK, Kjellstrand CM, Mauer SM. The management of life-threatening hyperammonemia: a comparison of several therapeutic modalities. J Pediatr. 1980;96:142–4.
Sadowski RH, Harmon WE, Jabs K. Acute hemodialysis of infants weighing less than five kilograms. Kidney Int. 1994;45:903–6.
Picca S, Dionisi-Vici C, Abeni D, Pastore A, Rizzo C, Orzalesi M, et al. Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators. Pediatr Nephrol. 2001;16:862–7.
Wen JX, Feldenberg LR, Abraham E, Sadiq F, Christensen KM, Braddock SR. Continuous venovenous hemodialysis via extracorporeal membrane oxygenation pump for treatment of hyperammonemia secondary to propionic acidemia in monochorionic diamniotic twin boys. J Pediatr. 2016;175:231–2.
Gander JW, Rhone ET, Wilson WG, Barcia JP, Sacco MJ. Veno-venous extracorporeal membrane oxygenation for continuous renal replacement in a neonate with propionic acidemia. J Extra Corpor Technol. 2017;49:64–6.
R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2015. http://www.r-project.org/.
Schwahn BC, Pieterse L, Bisset WM, Galloway PG, Robinson PH. Biochemical efficacy of N-carbamylglutamate in neonatal severe hyperammonaemia due to propionic acidaemia. Eur J Pediatr. 2010;169:133–4.
State of Tennessee Department of Health Family Health and Wellness. Tennessee Newborn Screening Program. http://www.tn.gov/assets/entities/health/attachments/NBS_Guide_Practitioners.pdf. 2011. Accessed 13 November 2017.
Naylor EW. Newborn screening for urea cycle disorders. Adv Exp Med Biol. 1982;153:9–18.
Summar ML, Koelker S, Freedenberg D, Le Mons C, Haberle J, Lee HS, et al. The incidence of urea cycle disorders. Mol Genet Metab. 2013;110:179–80.
Lovvorn HN 3rd, Hardison DC, Chen H, Westrick AC, Danko ME, Bridges BC, et al. Review of 1,000 consecutive extracorporeal membrane oxygenation runs as a quality initiative. Surgery. 2017;162(2):385-396.
Acknowledgements
JR Robinson receives salary and tuition support from the National Institutes of Health National Library of Medicine (T15 LM007450).
Funding
Supported by the National Institutes of Health National Library of Medicine (T15 LM007450 to JRR).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Robinson, J.R., Conroy, P.C., Hardison, D. et al. Rapid resolution of hyperammonemia in neonates using extracorporeal membrane oxygenation as a platform to drive hemodialysis. J Perinatol 38, 665–671 (2018). https://doi.org/10.1038/s41372-018-0084-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-018-0084-0
This article is cited by
-
Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy
Nature Reviews Nephrology (2020)